Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 22
Filter
1.
Neurosurg Rev ; 45(6): 3675-3681, 2022 Dec.
Article in English | MEDLINE | ID: mdl-36136255

ABSTRACT

Microscopic and endoscopic transsphenoidal surgeries represent the standard treatment for Cushing's disease (CD). At our institution a new exoscopic approach was implemented. After proof of the general use for transsphenoidal pituitary surgery, the aim of this study was to compare the exoscopic 4K3D video microscope with the microscopic transsphenoidal surgery for patients with CD. We conducted a retrospective analysis on 388 patients with CD treated in our medical center via microscopic transsphenoidal surgery (MTS) between January 2008 and July 2019 or via exoscopic transsphenoidal surgery (ExTS) between May 2019 and May 2021. Parameters investigated included histology, pre- and postoperative MRI with tumor size, pre- and postoperative ACTH and cortisol levels, duration of surgery, perioperative and postoperative complications as well as clinical outcome. Patients who underwent ExTS in CD experienced a lower incidence of SIADH/diabetes insipidus (p = 0.0164), a higher rate of remission (p = 0.0422), and a shorter duration of surgery (p < 0.0001), compared to MTS. However, there was no significant difference regarding new postoperative pituitary insufficiency and intraoperative CSF space opening. We found that ExTS had multiple benefits compared to MTS for tumor resection in case of CD. These results are in line with our previous publication on the general applicability of an exoscope in pituitary surgery. To our knowledge, this is the first clinical study proving the superiority of ExTS in CD. These results are promising, nevertheless further studies comparing exoscopic with the endoscopic approach are necessary to finally evaluate the utility of the new technique.


Subject(s)
Neoplasms , Pituitary ACTH Hypersecretion , Pituitary Neoplasms , Humans , Pituitary ACTH Hypersecretion/surgery , Retrospective Studies , Pituitary Gland/surgery , Neurosurgical Procedures/methods , Neoplasms/surgery , Treatment Outcome , Pituitary Neoplasms/surgery
2.
Neurosurg Focus ; 48(6): E9, 2020 06.
Article in English | MEDLINE | ID: mdl-32480363

ABSTRACT

OBJECTIVE: The purpose of this study was to analyze the clinical and biochemical outcome of consecutive patients with acromegaly after microscopic transsphenoidal surgery (MTS) at a single center over an 8-year period. METHODS: A retrospective analysis of patients with acromegaly treated via MTS between 2008 and 2015 at the authors' center was performed. The mean follow-up was 29 months (range 1-120 months). Parameters investigated included tumor size, pre- and postoperative insulin-like growth factor-I, growth hormone levels, pretreatment, perioperative complications, and clinical outcome. RESULTS: A total of 280 patients with acromegaly were treated surgically at the authors' center over the abovementioned time frame and were included in analyses. For 231 of these patients, complete follow-up data were available for evaluation. One hundred eighty-eight patients (81%) showed remission initially according to current criteria. So far, 23 of these patients relapsed in the further course, so that on follow-up 165 patients (71%) demonstrated full remission by surgery alone. Most patients in whom remission after surgery failed were treated with somatostatin receptor ligands and/or dopamine agonists as second-line treatment. The main postoperative complications included transient hyponatremia and diabetes insipidus (13/280; 4.6%). CSF leakage only occurred in 2 cases (2/280; 0.7%). No surgery-related death occurred. CONCLUSIONS: The data underline the effectiveness of MTS in acromegaly. Many patients with recurrent disease or incomplete tumor resection can be successfully managed pharmacologically.


Subject(s)
Acromegaly/diagnosis , Acromegaly/surgery , Postoperative Complications/diagnosis , Postoperative Complications/therapy , Acromegaly/blood , Adolescent , Adult , Aged , Aged, 80 and over , Child , Female , Follow-Up Studies , Humans , Male , Middle Aged , Postoperative Complications/blood , Remission Induction/methods , Retrospective Studies , Treatment Outcome , Young Adult
4.
J Neurol Surg A Cent Eur Neurosurg ; 80(5): 381-386, 2019 Sep.
Article in English | MEDLINE | ID: mdl-31075810

ABSTRACT

INTRODUCTION: Postoperative nausea and vomiting (PONV) is common in patients after craniotomy and may lead to severe postoperative complications. The aim of this study was to identify risk factors and postoperative complications associated with PONV in the context of perioperative high-dose dexamethasone administration. PATIENTS AND METHODS: In this prospective single-center study, all patients planned for elective craniotomy for supra- and infratentorial lesions were eligible to be included. Any PONV in a 24-hour period after craniotomy was recorded and analyzed with regard to time to postoperative complications and the administration of perioperatively administered high-dose dexamethasone. RESULTS: The overall PONV rate of 421 patients during a 9-month period was 18.1% (76 patients). Multivariate analysis revealed a significant association of PONV with female sex, infratentorial localization, age, and history of PONV. There was no association between PONV and postoperative complications such as intracranial hemorrhage, cerebrospinal fluid (CSF) leaks, or pneumonia. Perioperative administration of high-dose dexamethasone for prophylactic prevention of edema was the only significant risk factor for postoperative complications (odds ratio [OR]: 3.34; confidence interval [CI], 1.39-8.05; p < 0.01) with a highly significant association with the occurrence of CSF leaks (OR: 6.85; CI, 1.62-29.05; p < 0.01). CONCLUSION: The low PONV rate of 18.1% in this study may be the result of the frequent perioperative administration of high-dose dexamethasone for the prevention of edema. Our data indicate that perioperative high-dose dexamethasone is significantly associated with CSF leaks and can therefore not be recommended on a regular basis.


Subject(s)
Craniotomy/adverse effects , Dexamethasone/adverse effects , Postoperative Nausea and Vomiting/etiology , Adult , Aged , Brain Neoplasms/surgery , Dexamethasone/therapeutic use , Female , Humans , Male , Middle Aged , Prospective Studies , Risk Factors
5.
Growth Horm IGF Res ; 41: 64-70, 2018 08.
Article in English | MEDLINE | ID: mdl-29555234

ABSTRACT

OBJECTIVE: There is no ideal marker to identify residual tumor tissue after surgery in patients with acromegaly. The purpose was to elucidate if early postoperative hormone testing gives reliable information regarding complete resection of a GH-producing pituitary adenoma. DESIGN: Fourty-eight patients undergoing surgery for acromegaly from 04/2013-05/2014 were prospectively examined for random GH, IGF1, and GH levels after oral glucose tolerance testing (OGTT) in the early postoperative phase and on follow-up. Criterion for inclusion was a minimum follow-up of one year for each patient with respect to remission. RESULTS: Thirty-three patients showed GH suppression below 1 µg/l after OGTT in the early postoperative phase. Follow-up GH, IGF1 and OGTT tests confirmed the initial findings in 30 patients. The three remaining patients showed biochemical signs of persisting acromegaly. In the remaining 15 patients early postoperative GH suppression was above 1 µg/l. Of those, six patients went into remission during follow-up, nine patients without postoperative GH suppression <1 µg/l remained acromegalic. CONCLUSIONS: GH suppression to <1 µg/l as well as random GH levels below 1 µg/l in the early postoperative phase seem to be of good positive predictive value for long-term remission. However, several patients without suppression of GH to <1 µg/l in the early postoperative OGTT went into delayed remission. These results have to be taken into account prior to initiation of further therapy.


Subject(s)
Acromegaly/surgery , Adenoma/surgery , Biomarkers/analysis , Glucose Tolerance Test/methods , Human Growth Hormone/blood , Insulin-Like Growth Factor I/analysis , Postoperative Complications/diagnosis , Adult , Aged , Aged, 80 and over , Female , Follow-Up Studies , Humans , Incidence , Male , Middle Aged , Postoperative Complications/blood , Postoperative Complications/epidemiology , Prognosis , Prospective Studies , Young Adult
6.
Minerva Endocrinol ; 43(4): 430-434, 2018 Dec.
Article in English | MEDLINE | ID: mdl-29265782

ABSTRACT

New clinical symptoms from pituitary tumors during pregnancy are rare. Either the patient becomes symptomatic from a known lesion prior to conception during pregnancy, or it is a de-novo diagnosis due to acute symptoms. Non-functioning pituitary tumors can be subdivided into non-functioning pituitary adenomas and other pathologies. This review aims at giving a general overview as well as therapeutical considerations, taking into account that no specific recommendations/guidelines are available for this rare clinical problem.


Subject(s)
Pituitary Neoplasms/therapy , Pregnancy Complications, Neoplastic/therapy , Adenoma/therapy , Adult , Female , Humans , Pregnancy
7.
World Neurosurg ; 110: 180-188, 2018 Feb.
Article in English | MEDLINE | ID: mdl-29045853

ABSTRACT

OBJECTIVE: To identify symptomatic vasospasms as a rare complication after transsphenoidal surgery, with emphasis on management and outcomes. METHODS: In this retrospective study, the medical records of 1997 patients who underwent microscopic transsphenoidal surgery at our hospital between 2008 and 2016 were analyzed regarding postoperative vasospasm events, clinical management, and neurologic outcomes. RESULTS: Four patients (0.2%) were identified who developed neurologic deficits in the postoperative phase caused by proven vasospasms due to subarachnoid hemorrhage (SAH). All 4 patients were treated according to current state-of-the-art recommendations for SAH-triggered vasospasms and, as ultima ratio, intra-arterial spasmolysis. Nonetheless, all patients developed multilocular ischemic infarctions. Three patients recovered with no or only slight neurologic deficits (2 with a Glasgow Outcome Score [GOS] of 5; 1 with a GOS of 4), and 1 patient died, at 24 days after surgery. CONCLUSIONS: Although a rare complication, vasospasms after transsphenoidal surgery can lead to severe and multilocular ischemic infarctions with a wide variety of neurologic impairments. This rare complication should be considered in patients with unexpected postoperative neurologic deficits. Computed tomography (CT)/magnetic resonance imaging and (contrast-enhanced) CT/magnetic resonance angiography are appropriate diagnostic tools. Treatment of vasospasms, including the option of intra-arterial spasmolysis, should not be delayed.


Subject(s)
Neurosurgical Procedures/methods , Nose/surgery , Vasospasm, Intracranial/surgery , Adult , Angiography, Digital Subtraction , Humans , Magnetic Resonance Imaging , Male , Middle Aged , Retrospective Studies , Tomography, X-Ray Computed , Vasospasm, Intracranial/diagnostic imaging
8.
CNS Neurosci Ther ; 23(7): 620-626, 2017 Jul.
Article in English | MEDLINE | ID: mdl-28556544

ABSTRACT

INTRODUCTION: Pituicytoma is a rare neoplasm of the sella region. Tumor resection is the primary treatment option, but remains subtotal due to excessive bleeding in many cases. The search for alternative or additional treatment regimens is necessary. AIMS: We aimed to determine the receptor expression of pituicytoma to find alternatives or supplements to surgical therapy in the use of targeted therapies. METHODS: Pituicytoma samples were collected from three institutions between 2006 and 2015 and were stained for vascular endothelial growth factors (VEGF), thyroid transcription factor (TTF1), and somatostatin receptors (SSTR 2/3/5). The stains were classified from 0=no staining to +++=strong staining. A complementary retrospective analysis of the patient charts regarding sex, age, and primary symptoms, pituitary function, and perioperative complications was performed. RESULTS: Ten samples were analyzed; mean patient age was 57.8 years SD 16.3 years. Seven samples were acquired from male patients (one relapse) and three from female. All tumors stained strongly positive (+++) for VEGF-R. Six samples stained positive for TTF1. As for somatostatin receptors, three samples were slightly positive for SSTR 2; seven were negative. SSTR 3 was + in one, three were ++, three were +++, and three were 0. SSTR 5 stained +++ in 1, ++ in 5, + in 1, and 0 in three patients. CONCLUSIONS: Pituicytomas were generally positive for VEGFR and showed regular expression of SSTR 3 and 5 indicating a possible treatment option through targeted therapies in cases where resection remains insufficient. Further research is necessary as to whether tumor growth can be inhibited using these pathways.


Subject(s)
Pituitary Neoplasms/metabolism , Pituitary Neoplasms/pathology , Adult , Aged , DNA-Binding Proteins/metabolism , Female , Humans , Intraoperative Complications , Male , Middle Aged , Neoplasm Recurrence, Local , Pituitary Neoplasms/surgery , Postoperative Complications , Receptors, Somatostatin/metabolism , Retrospective Studies , Transcription Factors/metabolism , Vascular Endothelial Growth Factor A/metabolism , Young Adult
9.
Acta Neurochir (Wien) ; 159(7): 1219-1226, 2017 07.
Article in English | MEDLINE | ID: mdl-28204898

ABSTRACT

BACKGROUND: Thyrotropin-producing adenomas (TSHomas) account for approximately 1-2% of all pituitary tumors. Recently, there has been debate on primary treatment as some studies suggest a high rate of hypopituitarism after transsphenoidal surgery and therefore suggest primary use of somatostatin analogs (SSA) instead. We would like to challenge this assumption by presenting our single-center experience with transsphenoidal surgery for TSHoma. METHODS: Fifteen patients treated consecutively between May 2010 and December 2016 were analyzed for long-term postoperative remission and pituitary function. RESULTS: Data on the development of TSH, fT3 and fT4 were available for 12 of 15 patients (mean follow-up was 18 months, 8 patients >12 months), showing mean TSH levels of 1.289 mU/l (0.02-2.04, SD 0.66), mean fT3 levels of 3.76 pmol/l (0.5-6.16, SD 1.8) and mean fT4 levels of 16.5 pmol/l (11.7-21.9, SD 3.66). Six of those patients were substituted with a mean of 85.4 µg L-thyroxine after a median follow-up of 20.7 months. The other six patients did not receive L-thyroxine at a median follow-up of 15.5 months. One patient with a known tumor remnant on MRI stayed euthyreotic with cabergoline at the timepoint of follow-up 22 months after the operation. Control of the corticotrop axis was also available in 12 of 15 with no patient showing a corticotroph insufficiency in the long term. CONCLUSIONS: We argue that transsphenoidal surgery for TSHoma should be considered as the treatment of choice as remission following surgery is highly probable and postoperative hypopituitarism is very unlikely if patients are referred to centers with high pituitary surgery case loads.


Subject(s)
Adenoma/surgery , Hypopituitarism/etiology , Neurosurgical Procedures/methods , Pituitary Neoplasms/surgery , Postoperative Complications/etiology , Adolescent , Adult , Female , Humans , Hypopituitarism/drug therapy , Male , Middle Aged , Neurosurgical Procedures/adverse effects , Postoperative Complications/drug therapy , Thyrotropin/blood , Thyroxine/administration & dosage , Thyroxine/therapeutic use
10.
World Neurosurg ; 89: 540-51, 2016 May.
Article in English | MEDLINE | ID: mdl-26898497

ABSTRACT

BACKGROUND: Intracranial arteriovenous malformation (AVM) in children is a rare diagnosis. Little is known about factors determining AVM rupture and appropriate treatment strategies to prevent hemorrhage and associated disability. Available data suggest that children are subject to an increased risk for AVM rupture compared with adults. METHODS: In 46 pediatric patients with AVM, demographic factors, clinical presentation, angioarchitectural features, and treatment regimens as well as clinical and radiologic outcomes were retrospectively analyzed. First-line treatment option was microsurgical resection of the disease, with or without preoperative embolization. RESULTS: Twenty-four boys (52.2%) and 22 girls (47.8%) with a mean age on admission of 12.4 years (4-18 years) were included. Mean follow-up was 4 years (median, 1.5; range, 0.1-16.4). Thirty-one children presented with intracerebral hemorrhage (67.4%). Small AVMs (<3 cm) ruptured in 83.3% (n = 25) and were shown to be more prone to hemorrhage than larger ones (P < 0.01). Small AVM size (P < 0.01; odds ratio [OR], 0.12; 95% confidence interval [CI] 0.02-0.59) and exclusive deep venous drainage (P < 0.01; OR, 29.74; 95% CI, 2.45-4445.34) were independent risk factors for hemorrhage in the presented cohort. Good long-term outcome was associated with a high score on the Glasgow Coma Scale on admittance (P < 0.05; OR, 0.148; 95% CI, 0.03-0.73). CONCLUSIONS: Two-thirds of children with AVM are admitted with intracerebral hemorrhage. Microsurgical resection was successful as confirmed by radiologic studies in 95%, and 79.5% of patients presented in a good clinical condition on follow-up (modified Rankin Scale 0 or 1). Microsurgical treatment is recommended if the lesion is accessible and angioarchitectural risk factors favor definitive treatment.


Subject(s)
Cerebral Hemorrhage/diagnostic imaging , Cerebral Hemorrhage/etiology , Intracranial Arteriovenous Malformations/diagnostic imaging , Intracranial Arteriovenous Malformations/surgery , Adolescent , Angiography, Digital Subtraction , Brain/blood supply , Brain/diagnostic imaging , Cerebral Angiography , Cerebral Hemorrhage/epidemiology , Cerebral Hemorrhage/physiopathology , Child , Child, Preschool , Contrast Media , Female , Follow-Up Studies , Humans , Intracranial Arteriovenous Malformations/epidemiology , Intracranial Arteriovenous Malformations/physiopathology , Magnetic Resonance Imaging , Male , Multivariate Analysis , Risk Factors , Time Factors , Treatment Outcome
11.
Eur Spine J ; 25(5): 1349-1354, 2016 05.
Article in English | MEDLINE | ID: mdl-26769034

ABSTRACT

PURPOSE: It is undisputed for more than 200 years that the use of a parachute prevents major trauma when falling from a great height. Nevertheless up to date no prospective randomised controlled trial has proven the superiority in preventing trauma when falling from a great height instead of a free fall. The aim of this prospective randomised controlled trial was to prove the effectiveness of a parachute when falling from great height. METHODS: In this prospective randomised-controlled trial a commercially acquirable rag doll was prepared for the purposes of the study design as in accordance to the Declaration of Helsinki, the participation of human beings in this trial was impossible. Twenty-five falls were performed with a parachute compatible to the height and weight of the doll. In the control group, another 25 falls were realised without a parachute. The main outcome measures were the rate of head injury; cervical, thoracic, lumbar, and pelvic fractures; and pneumothoraxes, hepatic, spleen, and bladder injuries in the control and parachute groups. An interdisciplinary team consisting of a specialised trauma surgeon, two neurosurgeons, and a coroner examined the rag doll for injuries. Additionally, whole-body computed tomography scans were performed to identify the injuries. RESULTS: All 50 falls-25 with the use of a parachute, 25 without a parachute-were successfully performed. Head injuries (right hemisphere p = 0.008, left hemisphere p = 0.004), cervical trauma (p < 0.001), thoracic trauma (p < 0.001), lumbar trauma (p < 0.001), pelvic trauma (p < 0.001), and hepatic, spleen, and bladder injures (p < 0.001) occurred more often in the control group. Only the pneumothoraxes showed no statistically significant difference between the control and parachute groups. CONCLUSIONS: A parachute is an effective tool to prevent major trauma when falling from a great height.


Subject(s)
Accidental Falls/prevention & control , Craniocerebral Trauma/prevention & control , Fractures, Bone/prevention & control , Humans , Manikins , Pelvic Bones/injuries , Prospective Studies , Protective Devices , Research Design
12.
Neurosurg Focus ; 39(5): E5, 2015 Nov.
Article in English | MEDLINE | ID: mdl-26646929

ABSTRACT

OBJECT Cushing's disease (CD) may cause atrophy of different regions of the human brain, mostly affecting the hippocampus and the cerebellum. This study evaluates the use of 3-T MRI of newly diagnosed patients with CD to detect atrophic degeneration with voxel-based volumetry. METHODS Subjects with newly diagnosed, untreated CD were included and underwent 3-T MRI. Images were analyzed using a voxelwise statistical test to detect reduction of brain parenchyma. In addition, an atlas-based volumetric study for regions likely to be affected by CD was performed. RESULTS Nineteen patients with a mean disease duration of 24 months were included. Tumor markers included adrenocorticotropic hormone (median 17.5 pmol/L), cortisol (949.4 nmol/L), and dehydroepiandrosterone sulfate (5.4 µmol/L). The following values are expressed as the mean ± SD. The voxelwise statistical test revealed clusters of significantly reduced gray matter in the hippocampus and cerebellum, with volumes of 2.90 ± 0.26 ml (right hippocampus), 2.89 ± 0.28 ml (left hippocampus), 41.95 ± 4.67 ml (right cerebellar hemisphere), and 42.11 ± 4.59 ml (left cerebellar hemisphere). Healthy control volunteers showed volumes of 3.22 ± 0.25 ml for the right hippocampus, 3.23 ± 0.25 ml for the left hippocampus, 50.87 ± 4.23 ml for the right cerebellar hemisphere, and 50.42 ± 3.97 ml for the left cerebellar hemisphere. CONCLUSIONS Patients with untreated CD show significant reduction of gray matter in the cerebellum and hippocampus. These changes can be analyzed and objectified with the quantitative voxel-based method described in this study.


Subject(s)
Cerebellum/pathology , Hippocampus/pathology , Pituitary ACTH Hypersecretion/diagnosis , Adrenocorticotropic Hormone/blood , Adult , Aged , Atrophy/metabolism , Atrophy/pathology , Cerebellum/metabolism , Dehydroepiandrosterone Sulfate/blood , Female , Hippocampus/metabolism , Humans , Hydrocortisone/blood , Magnetic Resonance Imaging/methods , Male , Middle Aged , Pituitary ACTH Hypersecretion/blood , Prospective Studies , Young Adult
13.
Neurosurg Focus ; 39(2): E19, 2015 Aug.
Article in English | MEDLINE | ID: mdl-26235017

ABSTRACT

OBJECT Intramedullary spinal cavernoma (ISC) is a rare entity and accounts for approximately 5%-12% of all spinal vascular pathologies. The purpose of the present study was to examine the influence of clinical presentation, localization, and different surgical approaches on long-term outcome in patients treated for ISC. METHODS The authors performed a retrospective single-center study of 48 cases of ISC treated microsurgically over the past 28 years. Analyzed factors included preoperative clinical history, microsurgical strategies, neurological outcome (American Spinal Injury Association [ASIA] grade, Epstein and Cooper grade), and the occurrence of postoperative spinal ataxia. Univariate analysis was performed to identify factors influencing long-term outcome. RESULTS Preoperatively, 18.8% of all patients experienced a slow, progressive decline in neurological function and 33.3% suffered repetitive episodes of acute neurological deterioration over a time frame of months to years. Moreover, 16.7% noted the sudden onset of a severe neurological deficit, whereas 25% experienced the sudden onset of symptoms with a subsequent gradually progressive decline in neurological function. On long-term follow-up after treatment (mean ± SD, 79.3 ± 35.2 months), 70.8% of patients showed no change in neurological function, 6.3% suffered from a decline, and 22.9% improved neurologically. Thoracolumbar localization (p = 0.043), low preoperative Epstein and Cooper grade for the lower extremities (p < 0.001), and a low preoperative ASIA grade (p < 0.001) were identified as factors associated with an unfavorable outcome (ASIA Grade A-C). The rate of spinal ataxia related to surgical approach was 16.7%. CONCLUSION Postoperative neurological function in ISC patients is determined by the preoperative neurological status. On long-term follow-up after microsurgical treatment, 93.7% of patients presented with a stable or improved condition (ASIA grade); thus, definite microsurgical treatment should be considered as long as patients present with only mild symptoms after the diagnosis of symptomatic ISC.


Subject(s)
Hemangioma, Cavernous/surgery , Microsurgery/methods , Neurosurgical Procedures/methods , Recovery of Function , Spinal Cord Neoplasms/surgery , Adult , Aged , Female , Follow-Up Studies , Hemangioma, Cavernous/pathology , Humans , Male , Middle Aged , Postoperative Complications/epidemiology , Postoperative Complications/prevention & control , Postoperative Period , Retrospective Studies , Spinal Cord Neoplasms/pathology , Treatment Outcome
14.
J Neurol Surg A Cent Eur Neurosurg ; 76(6): 451-5, 2015 Nov.
Article in English | MEDLINE | ID: mdl-26140418

ABSTRACT

INTRODUCTION: Intraoperative micro-Doppler (IOMD), intraoperative digital substraction angiography (DSA), and microscope-integrated indocyanine green angiography are methods that guide neurosurgical resection of arteriovenous malformations (AVMs) in the brain and minimize the trauma of healthy tissue. In this study we emphasize the use of IOMD in AVM surgery, analyzing the advantages and the limitations of this method. Patients and METHODS: A total of 32 patients were diagnosed with an AVM. Supplying arteries and draining veins were analyzed regarding hemodynamic profiles, flow velocities, pulsatility index (PI), and resistance index (RI). Venous drainages were accompanied by arterial blood flow disturbances that showed typical characteristics in all cases. We set an angle of 60 degrees between the examined vessel and the probe to achieve a more reliable and comparable measurement. Postoperative DSA was performed in all patients. RESULTS: Supplying arterial blood vessels of AVMs could be identified by their characteristic blood flow profiles with PI < 0.7 and RI < 0.55. Drainage veins in all 32 cases showed normalized venous flow patterns without arterial flow turbulences at the end of the surgical procedure. Postoperative DSA revealed a residual AVM in one patient. CONCLUSIONS: IOMD constitutes a safe, accurate, and low-cost imaging modality for evaluating blood flow velocities and for optimal stepwise AVM elimination without unnecessary sacrifice of veins. PI and RI are reliable parameters in diagnosing cerebrovascular malformations, but systolic and diastolic flow velocities may vary to a greater extent. This phenomenon has never been elucidated previously and therefore needs to be emphasized when using this technique intraoperatively.


Subject(s)
Arteriovenous Fistula/diagnostic imaging , Arteriovenous Fistula/surgery , Intracranial Arteriovenous Malformations/diagnostic imaging , Intracranial Arteriovenous Malformations/surgery , Monitoring, Intraoperative/methods , Ultrasonography, Doppler, Transcranial/methods , Angiography, Digital Subtraction , Cerebral Angiography , Humans , Monitoring, Intraoperative/instrumentation , Treatment Outcome , Ultrasonography, Doppler, Transcranial/instrumentation
15.
Neurosurg Focus ; 38(2): E6, 2015 Feb.
Article in English | MEDLINE | ID: mdl-25639324

ABSTRACT

OBJECT Correct diagnosis and precise localization of adenomas in patients with Cushing's disease are essential for avoiding unsuccessful transsphenoidal pituitary exploration. In addition to the well-established inferior petrosal sinus sampling, preoperative cavernous sinus sampling (CSS) was introduced as a potentially improved way to predict adenoma lateralization. The authors present their results with CSS in a consecutive series of patients with Cushing's disease. METHODS During 1999-2014, transsphenoidal surgeries were consecutively performed in 510 patients with Cushing's disease. For most patients, suppression of cortisol in high-dose dexamethasone tests and stimulation of adrenocorticotropic hormone and cortisol after administration of corticotropin-releasing hormone were sufficient to prove the diagnosis of adrenocorticotropic hormone-dependent hypercortisolism. Of the 510 patients, 67 (13%) were referred to the department of neuroradiology for CSS according to the technique of Teramoto. The indications for CSS were unclear endocrine test results or negative MRI results. Data for all patients were retrospectively analyzed. RESULTS A central/peripheral gradient was found in 59 patients; lateralization to the left or right side was found in 51. For 8 patients with a central/peripheral gradient, no left/right gradient could be determined. For another 8 patients with equivocal test results, no central/peripheral gradient was found. No severe CSS-associated complications were encountered. Of the 51 patients who underwent transsphenoidal surgery, the predicted lateralization was proven correct for 42 (82%). CONCLUSIONS As MRI techniques have improved, the number of potential candidates for this invasive method has decreased in the past decade. However, because detecting minute adenomas remains problematic, CSS remains a useful diagnostic tool for patients with Cushing's disease.


Subject(s)
Cavernous Sinus/pathology , Pituitary ACTH Hypersecretion/diagnosis , Pituitary ACTH Hypersecretion/surgery , Pituitary Neoplasms/diagnosis , Pituitary Neoplasms/surgery , Adolescent , Adult , Aged , Child , Female , Humans , Magnetic Resonance Imaging/methods , Male , Middle Aged , Retrospective Studies , Young Adult
17.
J Pediatr Endocrinol Metab ; 28(1-2): 27-33, 2015 Jan.
Article in English | MEDLINE | ID: mdl-25503865

ABSTRACT

Surgery for craniopharyngiomas, especially in childhood and adolescence, has evolved from an era of aggressive strategies - with the primary goal of gross total removal and accepting an impaired functional outcome - to a more individually tailored therapy that avoids immediate treatment-related and long-term morbidity. Modern imaging techniques and a wider understanding of hypothalamic risk factors have led to surgical strategies adapted to the localization of these inhomogenously grown pathologies. Whereas purely infradiaphragmatic as well as supradiaphragmatic/infrachiasmatic tumors have a favorably surgical outcome with higher gross total resection rates in experienced hands, lesions within the third ventricle extending beyond the mammillary bodies remain a problem. The same is valid for lesions beyond 3 cm in diameter, more or less independent of their localization. Aside from the traditional microscopic approach via the subfrontal or pterional craniotomy, transsphenoidal approaches and other minimal invasive surgical methods, e.g., catheter implantation into cystic formations of the tumor have become popular. Radiotherapy, with its risks and limitations, can effectively be added to avoid recurrences. Nowadays, surgery as part of an interdisciplinary treatment strategy is still the typical first choice. However, taking the patient's long-term prognosis into considertaion, the surgical complication rates have to be minimized.


Subject(s)
Craniopharyngioma/surgery , Neurosurgical Procedures/methods , Pituitary Neoplasms/surgery , Postoperative Complications/prevention & control , Adolescent , Adult , Age of Onset , Animals , Child , Craniopharyngioma/complications , Craniopharyngioma/epidemiology , Humans , Morbidity , Neurosurgical Procedures/adverse effects , Pituitary Neoplasms/complications , Pituitary Neoplasms/epidemiology , Postoperative Complications/epidemiology , Survival Analysis , Treatment Outcome
18.
PLoS One ; 9(12): e114907, 2014.
Article in English | MEDLINE | ID: mdl-25502695

ABSTRACT

INTRODUCTION: Intraocular hemorrhage in patients suffering from aneurysmal subarachnoid hemorrhage is known as Terson's syndrome and is an underestimated but common pathology. We therefore designed a prospective single-blinded study to evaluate the validity of ocular ultrasound compared to the gold standard indirect funduscopy in the diagnosis of Terson's syndrome. MATERIAL AND METHODS: Fifty-two patients (104 eyes in total) suffering from aneurysmal subarachnoid hemorrhage were enrolled in this study. Two investigators independently performed a single-blinded ocular ultrasound using a standard intensive care ultrasound system to detect an intraocular hemorrhage. Indirect funduscopy following iatrogenic mydriasis served as the gold standard for confirmation or exclusion of an intraocular hemorrhage. Statistical analyses were performed to evaluate the sensitivity and specificity, positive and negative predictive values of the method as well as the learning curve of ocular ultrasound. RESULTS: Indirect funduscopy detected Terson's syndrome in 11 of 52 (21.2%) respectively in 21 of 104 (20.2%) eyes in patients suffering from subarachnoid hemorrhage. Sensitivity and specificity increased with the number of ocular ultrasound examinations for both investigators, reaching 81.8% and 100% respectively. Positive and negative predictive values were different for both investigators (63.6% vs. 100% positive and 100% vs. 95.7% negative) but were both correlated to the amount of intraocular hemorrhage. A low Glasgow Coma scale (p = 0.015) and high Hunt & Hess grade (p = 0.003) was associated with a higher rate of Terson's syndrome. CONCLUSIONS: Ocular ultrasound using standard ultrasound equipment has been confirmed as a reliable, easy-to-handle bedside screening tool for detecting Terson's syndrome. Nevertheless funduscopy remains the gold standard to detect Terson's syndrome.


Subject(s)
Eye/diagnostic imaging , Prognosis , Retinal Detachment/diagnostic imaging , Subarachnoid Hemorrhage/diagnostic imaging , Adult , Aged , Aged, 80 and over , Aneurysm , Eye/physiopathology , Female , Glasgow Coma Scale , Humans , Learning Curve , Male , Middle Aged , Retinal Detachment/complications , Retinal Detachment/physiopathology , Subarachnoid Hemorrhage/complications , Subarachnoid Hemorrhage/physiopathology , Ultrasonography
19.
J Neurosurg Anesthesiol ; 26(3): 216-9, 2014 Jul.
Article in English | MEDLINE | ID: mdl-24810990

ABSTRACT

BACKGROUND: Postoperative nausea and vomiting (PONV) is common after general anesthesia and are reported by approximately 20% to 25% of all patients and up to 39% of patients undergoing neurosurgical procedures. The most common standard prophylaxis is a single application of 4 mg of dexamethasone before initiating anesthesia. Dexamethasone is known to suppress adreno-corticotroph hormone and cortisol levels. The objective was to find out whether this prophylaxis has an effect on the postoperative levels of cortisol in patients undergoing transsphenoidal pituitary surgery, and therefore simulates pituitary deficiency. PATIENTS AND METHODS: A retrospective analysis of the files of 136 consecutive patients who were operated during a course of 6 months were included. Nineteen patients with a known history of PONV received a standard dose of 4 mg of dexamethasone perioperatively. Blood tests were drawn at the first postoperative day and were compared with blood tests of patients who had no history of PONV and therefore received no prophylaxis. RESULTS: Patients who were treated with a dexamethasone PONV prophylaxis showed no significant changes in cortisol levels; preoperative median of 93 µg/L (range, 39 to 427) and a postoperative median of 87 µg/L (range, 10 to 733; P=0.798) opposed to patients who did not receive such treatment; preoperative cortisol 114 µg/L (range, 10 to 387) and postoperative levels of 273 µg/L (range, 10 to 1352; P<0.001). CONCLUSIONS: As early postoperative blood checks of the cortisol levels yield important information about potential pituitary sufficiency after transsphenoidal surgery, the probability that dexamethasone PONV prophylaxis suppresses postoperative cortisol levels should be considered.


Subject(s)
Antiemetics/adverse effects , Dexamethasone/adverse effects , Hypothalamo-Hypophyseal System/drug effects , Pituitary Gland/surgery , Pituitary-Adrenal System/drug effects , Postoperative Nausea and Vomiting/prevention & control , Sphenoid Bone/surgery , Adolescent , Adrenocorticotropic Hormone/blood , Adult , Aged , Antiemetics/therapeutic use , Dexamethasone/therapeutic use , Female , Humans , Hydrocortisone/blood , Male , Middle Aged , Neurosurgical Procedures/adverse effects , Retrospective Studies , Young Adult
20.
Growth Horm IGF Res ; 24(2-3): 71-5, 2014.
Article in English | MEDLINE | ID: mdl-24726277

ABSTRACT

PURPOSE: Data suggests that substitution of GH in GH-deficient patients may improve quality-of-life and reduce insufficiency-associated-symptoms. Unlike in corticotroph, thyreotroph, or gonadotroph-insufficiency, GH-substitution is usually not started within the first 6-12months after surgery. We aimed to investigate the effect of early-GH-substitution on body-composition, metabolic and pituitary-laboratory-tests, and quality-of-life. METHODS: Data was reviewed from 21 adult-patients who were diagnosed with insufficiency of GH-axis using insulin-hypoglycemia-test. We retrospectively assessed body-composition, metabolic and pituitary-laboratory-tests and quality-of-life for a period of 52-weeks after pituitary-surgery in patients with early GH-substitution (= treated-group, 11-patients) and no GH-substitution (= untreated group, 10-patients). RESULTS: Follow-up-IGF-I-levels of the treated-group stayed within the normal range and differed significantly from the untreated-group. Bioelectrical-impedance-analysis showed a significant decrease of impedance, a significant increase of lean-body-mass and a significant difference in health status in the treated group (p<0.05). Average increase in HDL-level was 2.1mg/dl in the untreated compared to an average decrease of 0.2mg/dl in the treated-group. Lp(a)-levels were reduced by 4.1mg/dl in the treated and by 2.7mg/dl in the untreated-group. Both groups showed an initial-mean-life-satisfaction below average (-0.9 and -1.2). Within one year after surgery mean-health-status improved in both groups. The difference in health-status after 1-year compared to the health-status of the previous year was statistically different between both groups with a greater benefit in the treated-group. Finally there was a trend detectably pointing towards an improvement in pituitary-function (LH- and FSH-recovery) if GH was substituted. CONCLUSION: Early GH-substitution leads to a significant improvement in quality-of-life and body-composition after pituitary-surgery. It is possible that pituitary-function recovers more with early-GH-substitution.


Subject(s)
Adenoma/drug therapy , Adenoma/surgery , Hormone Replacement Therapy , Human Growth Hormone/deficiency , Human Growth Hormone/therapeutic use , Pituitary Neoplasms/drug therapy , Pituitary Neoplasms/surgery , Adenoma/epidemiology , Adenoma/pathology , Adult , Aged , Chemotherapy, Adjuvant , Female , Humans , Male , Middle Aged , Pituitary Neoplasms/epidemiology , Pituitary Neoplasms/pathology , Postoperative Period , Quality of Life , Retrospective Studies , Surveys and Questionnaires , Treatment Outcome , Tumor Burden , Work Capacity Evaluation
SELECTION OF CITATIONS
SEARCH DETAIL
...